2010
  1. Deacon,C.F. and Holst,J.J.
    Linagliptin, a xanthine-based dipeptidyl peptidase-4 inhibitor with an unusual profile for the treatment of type 2 diabetes
    Expert Opin Investig Drugs19, 133-140. PubMed  Europe PubMed DOI  I